Mutation Profile Prognostic Value in Stage III Non Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy (CRT)

被引：0
|
作者：
Boros, Angela [1 ]
Lacroix, Ludovic [2 ]
Lancas, Benjamin [3 ]
Adam, Julien [2 ]
Pignon, Jean-Pierre [3 ]
Caramella, Caroline [4 ]
Planchard, David [5 ]
Levy, Antonin [1 ]
De Montpreville, Vincent [6 ]
Deutsch, Eric [1 ]
Besse, Benjamin [5 ]
Le Pechoux, Cecile [1 ]
机构：
[1] Gustave Roussy, Radiat Oncol, Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Med Biol & Pathol, Villejuif, France
[3] Gustav Roussy, Biostat, Villejuif, France
[4] Gustav Roussy, Radiol, Villejuif, France
[5] Gustav Roussy, Med Oncol, Villejuif, France
[6] Ctr Chirurg Marie Lannelongue, Pathol, Le Plessis Robinson, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Stage III NSCLC; chemo-radiation; Mutation profile; prognostic value;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI07.08
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [1] Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)
    Adam, J.
    Boros, A.
    Lacas, B.
    Lacroix, L.
    Pignon, J. P.
    Caramella, C.
    Planchard, D.
    Levy, A.
    Besse, B.
    Le Pechoux, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S604 - S604
  • [2] Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value
    Boros, A.
    Lacroix, L.
    Lacas, B.
    Adam, J.
    Pignon, J. P.
    Caramella, C.
    Planchard, D.
    Levy, A.
    Montpreville, V.
    Deutsch, E.
    Besse, B.
    Le Pechoux, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S595 - S595
  • [3] Efficacy of Chemo-Radiotherapy (CRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression
    Adam, Julien
    Boros, Angela
    Lacas, Benjamin
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [4] Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy
    Kawaguchi, T
    Matsumura, A
    Iuchi, K
    Ishikawa, S
    Maeda, H
    Fukai, S
    Komatsu, H
    Kawahara, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 7 - 11
  • [5] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [6] Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer
    Chiramel, Jaseela
    Tay, Rebecca
    Califano, Raffaele
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S991 - S994
  • [7] A prognostic clinical and circulating biomarker model to identify futile chemo-radiotherapy (CRT) in stage III NSCLC
    Vaes, R. D. W.
    Hendriks, L.
    Houben, R.
    Degens, J.
    Cortiula, F.
    De Ruysscher, D.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S749 - S749
  • [8] Recurrence pattern and its prognostic impact following definitive chemo-radiotherapy in stage III non-small cell lung cancer
    Saigi Morgui, M.
    Rullan Iriarte, A. J.
    Bergamino, M.
    Navarro, A.
    Arnaiz, M. M.
    Palmero, R.
    Plana Serrahima, M.
    Mesia, C.
    Padrones, S.
    Aso, S.
    Ruffinelli Rodriguez, J.
    Navarro, V.
    Brao, I.
    Nadal, E.
    Cardenal Alemany, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] Preoperative chemo-radiotherapy in stage III non-small cell lung cancer: a progress in integration of chemo-radiation
    Choi, NC
    [J]. TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 219 - 237
  • [10] Sequential Versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer
    EL Sharouni, SY
    Kal, HB
    Battermann, JJ
    Schramel, FMNH
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 495 - 505
12345